A new blood test for the existence or remission of cancer in a non-terminal patient is gaining acceptance. Non-terminal means any patients whose cancer is not in the terminal phase of the disease. It is called AMAS and examines the levels of anti-malignin antibody which is elevated in malignancy and returns to normal values in cases of remission. It purports to be ninety to ninety five percent accurate. It is considered to be an aid in diagnosis and detection. Patients can use it as an indicator of whether of not a treatment is working, i.e. cancer is going into remission, or returning.

The problem is that many doctors are unaware of the test and may not be inclined to order it. It then becomes a challenge to either convince your doctor to order the test or find a doctor, or walk in health clinic, that will. The test, and research information for your doctors' review, can be obtained from:

Oncolab
36 The Fenway
Boston, MA 02215
1-800-922-8378